Monheim, August 19, 2011 – Bayer CropScience has received the final approval for its herbicide tolerant soybean technology from the National Ministry of Agriculture in Argentina. The Liberty Link® technology conveys tolerance to the glufosinate-ammonium herbicide Liberty® for effective, broad spectrum weed control
"The approval of this technology for soybeans shows a very positive and constructive position towards plant biotechnology in Argentina. This is an important step towards more sustainable and innovative solutions for farmers in that country,” said Mathias Kremer, Head of the BioScience business unit of Bayer CropScience. “The approval in Argentina is another important step towards regional regulatory harmonization for soybean innovation and trade. It further strengthens the growth of our seeds and traits business in soybeans,” he said.
Weed resistance is evolving rapidly, driving the need for sustainable solutions like new herbicide tolerance traits, especially in soybeans. The Liberty Link trait will deliver an important and effective weed management tool as an alternative to using glyphosate herbicides in genetically modified soybeans which are currently grown on 18 million hectares in Argentina.
Bayer CropScience plans to launch its first genetically modified soybeans in Argentina once further approvals for important stacked traits become available. Liberty Link will be combined with these traits and then launched in the forthcoming years.
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 6.830 billion (2010), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 20,700 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
Richard Breum, Tel. +49 2173 38-3270
Find more information at www.bayercropscience.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.